The Pune-based SII had sought the permission from the DCGI to conduct Phase 3 study to evaluate the safety and immunogenicity of Covovax.
Covid-19: SII's Covovax vaccine recommended for Phase 3 trial as booster dose in adults
Tags: adults, booster, COVID-19, covid-19 booster dose, COVID-19 vaccine, COVID19, Covovax, DGCI, dose, Phase, recommended, SII, SII039s, trial, Vaccine